Figure 1.
Time series for each case, displaying cycle threshold (Ct) values of SARS-CoV-2 on reverse-transcription quantitative polymerase chain reaction over time for 7 cases. Cases without follow-up testing data (n = 2) and cases where upper respiratory tract sampling was consistently negative (n = 2) are not shown. Sampling date is presented in relation to the start date of the final course of nirmatrelvir/ritonavir. Samples are shown up to 90 days prior to this final course. Samples reported as not detected are set to Ct = 46 for the purpose of graphical representation. Multiple platforms were used for testing, and no correction or normalization between platforms was conducted.

Time series for each case, displaying cycle threshold (Ct) values of SARS-CoV-2 on reverse-transcription quantitative polymerase chain reaction over time for 7 cases. Cases without follow-up testing data (n = 2) and cases where upper respiratory tract sampling was consistently negative (n = 2) are not shown. Sampling date is presented in relation to the start date of the final course of nirmatrelvir/ritonavir. Samples are shown up to 90 days prior to this final course. Samples reported as not detected are set to Ct = 46 for the purpose of graphical representation. Multiple platforms were used for testing, and no correction or normalization between platforms was conducted.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close